Mohs Micrographic Surgery for Basal Cell Carcinoma: Predictive Factors for Increased Stages and Relative Defect Sizes
Australasian Journal of Dermatology · 2025
DOI: 10.1111/ajd.14535 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Australasian Journal of Dermatology, 2025. Verfasst von Subashini Gnanendran und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Skin Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Mohs Surgery, Basal Cell Carcinoma, Skin Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Keratinocyte cancers (KCs), including basal cell carcinomas (BCCs), are the most common cancers in Australia. While Mohs micrographic surgery (MMS) is the gold standard treatment, it can be resource intensive, particularly for cases requiring multiple stages. This study aimed to identify predictors of increased MMS stages and a greater tumour‐to‐defect size discrepancy in head and neck BCC. A retrospective analysis of the Mohs Electronic Database at the Skin Hospital's Westmead and Darlinghurst sites in Sydney, Australia was conducted from October 2012 to December 2022, including 18,346 BCC cases. The main outcomes were the number of MMS stages and the relative defect size, with covariates including patient age, sex, tumour characteristics and Mohs specialist factors. Older patients required more stages (1.65 vs. 1.90; p < 0.01) and had larger relative defect sizes (2.10 vs. 2.90; p < 0.01). Larger tumours required more stages (1.69 vs. 1.94; p < 0.01), while smaller tumours had disproportionately larger relative defects (5.94 vs. 2.08; p < 0.01). Nodular BCC required fewer stages (1.63; p < 0.01) and had the smallest defects (2.11; p < 0.01). Notably, superficial BCCs required a similar number of MMS stages as traditionally aggressive subtypes. Tumours of the ear, eye and nose required more stages than other cosmetic units (2.05, 2.02, 1.94; p < 0.01). Increased Mohs experience reduced the number of stages (2.18 vs. 1.83; p = 0.03) and relative defect sizes (3.49 vs. 2.50; p < 0.01). Patient age, tumour size, subtype, cosmetic unit and Mohs specialist experience influence MMS stages and relative defect sizes in head and neck BCC. Recognising these factors can enhance surgical planning, personalise treatment strategies and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Skin Hospital, Sydney, New South Wales, Australia.
- Royal North Shore Hospital, St Leonards, New South Wales, Australia.
- WSLHD Research and Education Network, Westmead Hospital, Westmead, New South Wales, Australia.
- Central Clinical School, Faculty of Medicine, University of Sydney, Camperdown, New South Wales, Australia.
ORCID-Profile: Marra Aghajani, Gilberto Moreno Bonilla
Zitieren
APA
Gnanendran, S., Aghajani, M., Elhindi, J., Lee, S., & Bonilla, G. M. (2025). Mohs Micrographic Surgery for Basal Cell Carcinoma: Predictive Factors for Increased Stages and Relative Defect Sizes. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14535
Vancouver
Gnanendran S, Aghajani M, Elhindi J, Lee S, Bonilla GM. Mohs Micrographic Surgery for Basal Cell Carcinoma: Predictive Factors for Increased Stages and Relative Defect Sizes. Australasian Journal of Dermatology. 2025. doi:10.1111/ajd.14535
BibTeX
@article{Gnanendran2025,
author = {Gnanendran, Subashini and Aghajani, Marra and Elhindi, James and Lee, Simon and Bonilla, Gilberto Moreno},
title = {Mohs Micrographic Surgery for Basal Cell Carcinoma: Predictive Factors for Increased Stages and Relative Defect Sizes},
journal = {Australasian Journal of Dermatology},
year = {2025},
doi = {10.1111/ajd.14535}
}
EUVIMED